Viewing Study NCT01439061


Ignite Creation Date: 2025-12-24 @ 12:23 PM
Ignite Modification Date: 2025-12-27 @ 9:28 PM
Study NCT ID: NCT01439061
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2011-09-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module